BioLineRx Ltd. to Present at the 2013 Biotechnology Industry Organization (BIO) CEO & Investor Conference in New York on February 12th

Published: Jan 31, 2013

BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the 2013 BIO CEO & Investor Conference in New York.

Back to news